Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), widely prescribed for type 2 diabetes and obesity, have been proposed to modulate testosterone levels
Hiddemann W, Buechner T, Andreeff M , Woermann B, Clarkson BD
About the Study Wegovy conversations included more depression mentions: Posts about this semaglutide brand referenced depression at a higher rate (1.57%) than other GLP-1 RAs
Tissue-based map of the human proteome
As of November 2025, 2,914 lawsuits have been consolidated by the judicial panel in MDL 3094 in the Eastern District of Pennsylvania under Judge Karen S
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the action of the naturally occurring hormone GLP-1